Murray Dallan 4
4 · Sarepta Therapeutics, Inc. · Filed May 6, 2024
Insider Transaction Report
Form 4
Murray Dallan
Chief Customer Officer
Transactions
- Sale
Common Stock
2024-05-02$140.00/sh−3,635$508,900→ 18,125 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.